Tag:
obatoclax
Latest Headlines
Latest Headlines
Cephalon scoops up cancer drugs in $525M Gemin X buyout
Intrigued by a lead program aimed at retriggering cell death in order to fight cancer, Cephalon ( $CEPH ) has gobbled up the small biotech Gemin X with a $225 million down payment and up to $300
Gemin X books $16M Series D as it pursues PhIIb cancer trial
Malvern, PA-based Gemin X Pharmaceuticals has rounded up $16 million in a Series D round led by two existing investors. The money will be put to use advancing the developer's new cancer therapies,
